Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson's disease: a follow-up study.

@article{Trsdttir2006CeruloplasminAS,
  title={Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson's disease: a follow-up study.},
  author={Gudlaug T{\'o}rsd{\'o}ttir and Sigurlaug Sveinbj{\"o}rnsd{\'o}ttir and Jakob Kristinsson and J{\'o}n Snaedal and Torkell J{\'o}hannesson},
  journal={Journal of the neurological sciences},
  year={2006},
  volume={241 1-2},
  pages={53-8}
}
In this follow-up study concentration, oxidative activity and specific oxidative activity of ceruloplasmin (CP) in serum and the activity of superoxide dismutase (SOD1) in erythrocytes were reexamined in 28 of originally 40 patients with Parkinson's disease (PD), and their age- and gender-matched controls. The mean CP and SOD1 parameters were significantly lower in the patients than in the controls. SOD1 activity and age of the patients were inversely correlated. The patients were divided into… CONTINUE READING